PCSK9: A novel inflammation modulator in atherosclerosis?-Reference-Cited by-同舟云学术

PCSK9: A novel inflammation modulator in atherosclerosis?

Published:2018-09-24 Issue:3 Volume:234 Page:2345-2355
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Tang Zhi‐Han¹²^ORCID,Li Tao‐Hua¹,Peng Juan¹²,Zheng Jie¹,Li Ting‐Ting¹,Liu Lu‐Shan¹,Jiang Zhi‐Sheng¹,Zheng Xi‐Long²

Affiliation:

1. Department of Pathophysiology, Institute of Cardiovascular Disease Key Lab for Arteriosclerology of Hunan Province, University of South China Hengyang Hunan China

2. Department of Biochemistry and Molecular Biology The Libin Cardiovascular Institute of Alberta, The University of Calgary, Health Sciences Center Calgary Alberta Canada

Funder

National Natural Science Foundation of China

Education Department of Hunan Province

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.27254

Reference122 articles.

1. Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome

2. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia